Researchers entered and left COVID-19 labs without changing their coats, resulting in contamination of tests
MONDAY, April 20, 2020 (HealthDay News) — The first COVID-19 tests in the United States were ineffective due to poor laboratory practices at the U.S. Centers for Disease Control and Prevention, the U.S. Food and Drug Administration said.
The CDC’s own manufacturing standards were violated by two of the agency’s three labs in Atlanta that created the COVID-19 test kits. As a result, the CDC sent ineffective tests to nearly all of the 100 state and local public health labs, according to the FDA, The New York Times reported.
A major problem was that researchers entered and left COVID-19 laboratories without changing their coats, officials said. That resulted in contamination of tests sent to public health labs, making them unusable, The Times reported.
“CDC did not manufacture its test consistent with its own protocol,” FDA spokeswoman Stephanie Caccomo said in a statement. As a result of the manufacturing problems with the tests, the CDC had to delay the launch of a nationwide COVID-19 detection program for a month, and the United States lost ground in its fight against COVID-19, The Times reported.
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer 
Age-, Joint-Specific Ultrasound Reference Values Set for Healthy Joints 
Retinal Imaging Can ID Atrial Fibrillation Years Before Diagnosis 
U.S. Adults May Not Understand Their Risk for Vascular Disease 
Lower Cognitive Functioning During 60s Linked to Subsequent Stroke Risk 
Nearly 1 in 10 Older Adults Used Cannabis in the Past Year 
Polypharmacy of Prescription Medications Increased for U.S. Older Adults 
Pharmacist-Led Med Review Improves Medication Quality in Older Patients With Cancer 
.jpg)
.jpg)